News | October 06, 2014

Grant Awarded to See if Echo Can Detect Significant Coronary Lesions in Chest Pain Patients

ASEF Grant Echo Can Dt Coronary Lesions Chest Pain Patients

Dr. Victor Mor-Avi of the University of Chicago accepts the 2014 ASEF Research Award at Summit 2014.

October 6, 2014 — The ASE Education and Research Foundation hosted a one-day event, Value-Based Healthcare: Summit 2014, Sept. 12 in Washington, D.C., which gathered thought leaders from across the healthcare spectrum to discuss cardiac imaging in the new value-based healthcare paradigm. The Summit culminated with the announcement that the ASE Foundation’s largest research grant in its history, a $200,000 multi-year grant, has been awarded to a research team from the University of Chicago led by Victor Mor-Avi, Ph.D., FASE, director of cardiac imaging research. The team also includes Amit R. Patel, M.D., director of cardiac magnetic resonance imaging and computed tomography; Francesco Maffessanti, Ph.D., post-doctoral scholar; and Roberto M. Lang, M.D., FASE, director of cardiac imaging laboratories.

The proposal, titled Echocardiographic Evaluation of Hemodynamic Significance of Coronary Stenosis in Patients with Chest Pain Undergoing CT Angiography, aims to utilize 3-D echocardiography in patients with acute chest pain as a way to assess the functional significance of coronary stenosis detected by computed tomography coronary angiography (CTCA). According to Mor-Avi, “in the United States alone every year, more than 8 million people require emergency evaluation for acute chest pain, with the estimated cost of over $10 billion.” While non-invasive CTCA has become widely accepted as an effective first-line diagnostic tool in these patients, abnormal findings on this test often result in downstream stress testing. Specifically, choosing appropriate management for patients with intermediate-grade stenosis is challenging because the impact of the disease is unclear.

Mor-Avi explained that this project “will explore the possibility of ‘fusion’ of CTCA and 3-D echocardiography for combined assessment of coronary stenosis and its functional significance, which may help in identifying patients who need intervention, and may thus have important implications in terms of reducing the number of unnecessary tests and resulting in significant savings.”

Cardiovascular ultrasound, also known as echocardiography, is the most widely used imaging technique to diagnose heart disease, performed on more than 20 million patients in the United States each year. Yet in this era of growing Medicare expenditures and federal budget deficits, increasing emphasis has been placed on demonstrating the value of any given test or procedure. As Summit Chair Benjamin F. Byrd III, M.D, FASE noted in his opening address, one of the primary goals of Summit 2014. was to “bring decision makers together to foster proactive conversation on the ways to demonstrate the ‘value’ of imaging, especially echocardiography, in future U.S.-based healthcare.” Providing funding for this research project tangibly demonstrates the Society’s commitment to fostering innovation in clinical care based on data-driven decisions.

As the largest global organization for cardiovascular ultrasound imaging, the American Society of Echocardiography (ASE) is the leader and advocate, setting practice standards and guidelines. Comprised of over 16,000 physicians, sonographers, nurses and scientists, ASE is a strong voice providing guidance, expertise and education to its members with a commitment to improving the practice of ultrasound and imaging of the heart and cardiovascular system for better patient outcomes. 

For more information: www.asecho.org

Related Content

A CT calcium scoring image showing calcified plaques in coronary vessel segments. The higher the calcium content of the vessels, the high risk the patient is for a heart attack event. CAC exam

A CT calcium scoring image showing calcified plaques in coronary vessel segments. The higher the calcium content of the vessels, the higher risk the patient is for a heart attack event. Image courtesy of Canon Medical Systems.

Feature | Computed Tomography (CT) | October 17, 2018 | Dave Fornell, Editor
A picture is worth a thousand words, and to patients concerned about their health, detailed images of the coronary an
Abdominal Aortic Calcification May Signal Future Heart Attack

Image from computed tomography (CT) colonography shows segmented abdominal aortic calcification measured with semiautomated CT tool on coronal image. Within region of interest over aorta selected by user, tool automatically segments and quantifies aortic calcification (shown in blue). 

Image Credit: O’Connor S D, Graffy P M, Zea R, et al. Does nonenhanced CT-based quantification of abdominal aortic calcification outperform the Framingham Risk Score in predicting cardiovascular event sin asymptomatic adults? Radiology doi: 10.1148/radiol.2018180562. Published online Oct. 2, 2018. © RSNA.

News | Computed Tomography (CT) | October 12, 2018
Computed tomography (CT)-based measures of calcification in the abdominal aorta are strong predictors of heart attacks...
Siemens Healthineers Announces First U.S. Install of Somatom go.Top CT
News | Computed Tomography (CT) | September 17, 2018
September 17, 2018 — The Ohio State University Wexner Medical Center in Columbus recently became the first healthcare
Key Patient Preparations for a CT Scan
News | Computed Tomography (CT) | September 05, 2018
The Center for Diagnostic Imaging (CDI) in Miami recently released a list of important preparations patients should...
Videos | Computed Tomography (CT) | July 25, 2018
A discussion with Patricia Dickson, LRT(CT), director of imaging and outpatient services, Capital Cardiology Associat
Videos | Computed Tomography (CT) | July 23, 2018
Ed Nicol, M.D., FSCCT, MBA, head of cardiac CT, Royal Brompton Hospital, London, and chair of the Society of Cardiova
Videos | Computed Tomography (CT) | July 17, 2018
An interview with Patrick Serruys, M.D., Ph.D., Imperial College London, principal investigator of the SYNTAX III Tri
Zebra Medical Vision Announces FDA 510(k) Clearance of Coronary Calcium Algorithm
Technology | Computed Tomography (CT) | July 12, 2018
Zebra Medical Vision has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Coronary...
IAC Awards First CT Accreditation for a Mobile Stroke Unit
News | Computed Tomography (CT) | July 09, 2018
The Intersocietal Accreditation Commission (IAC) recently recognized the University of Tennessee Health Science Center...
FFR-CT may soon replace invasive angiography for coronary lesion assessment. #EuroPCR 

Anexample of a clinical case of CT-FFR, which can derive the FFR numbers for their entire coronary tree using a noninvasive CT scan.

Feature | Computed Tomography (CT) | May 29, 2018
May 29, 2018 — Results from the innovative SYNTAX III Revolution Trial [1] underline the effectiveness of evolving no
Overlay Init